NasdaqGS - Nasdaq Real Time Price • USD
Elevation Oncology, Inc. (ELEV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AISLING CAPITAL IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 29, 2021 | -- |
| CLACKSON TIMOTHY P Director | Stock Gift | Sep 1, 2023 | 47,330 |
| CORMORANT ASSET MANAGEMENT ,L.P Former | Purchase | Jun 29, 2021 | -- |
| FERRA JOSEPH J. JR. Chief Executive Officer | Conversion of Exercise of derivative security | Mar 15, 2024 | 85,680 |
| FURLONG TAMMY CPA Chief Financial Officer | Conversion of Exercise of derivative security | Feb 15, 2024 | 797 |
| QIMING U.S. HEALTHCARE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 29, 2021 | -- |
| VENBIO GLOBAL STRATEGIC FUND III, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale | May 25, 2022 | -- |
| VERTEX GLOBAL HC FUND II PTE. LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 29, 2021 | 2,307,640 |
Related Tickers
CLSD Clearside Biomedical, Inc.
1.3400
+6.35%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
INAB IN8bio, Inc.
1.0400
0.00%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
BCAB BioAtla, Inc.
2.5400
+12.89%
ACRV Acrivon Therapeutics, Inc.
8.46
-0.12%
IKNA Ikena Oncology, Inc.
1.3000
-0.76%
RZLT Rezolute, Inc.
2.6600
+2.31%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%